Xiaojian Xu

机构：Capital Medical University, Beijing Institute of Neurosurgery, Jiangsu Hengrui Medicine (China) · ORCID：0000-0002-5264-8963

发表论文 119 篇 · 总被引 928 次 · h-index 13

代表论文

• Integrated metabolomics and network pharmacology to reveal the mechanisms of Shexiang Baoxin pill against atherosclerosis (2024 · Phytomedicine · 被引 31)
• Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions (2024 · Journal of Translational Medicine · 被引 28)
• The peptide from C- Phycocyanin alleviates myocardial ischemia-reperfusion injury by suppressing ferroptosis via upregulating UCHL3 (2025 · Free Radical Biology and Medicine · 被引 9)
• Abstract CT084: A phase 1 study of LY4101174 (ETx-22), an antibody-drug conjugate targeting nectin-4, in patients with advanced or metastatic urothelial cancer and other solid tumors (trial in progress) (2024 · Cancer Research · 被引 9)
• Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury (2025 · Frontiers in Immunology · 被引 5)
• Comprehensive bioinformatics analysis and systems biology approaches to identify the interplay between COVID-19 and pericarditis (2024 · Frontiers in Immunology · 被引 5)